Comparison of Serological Test s for the Virus Chicken Pox Virus (VZV) and Correlation With the Patient's Memory of the Infection or Vaccination
NCT02775422 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 308
Last updated 2020-08-25
Summary
Comparison of the sensibility and specificity of 3 different serological tests and evaluation of chicken pox immunity in pregnant women.
Secondary goals :
* Correlation memory / Immunity;
* Prevalence of VZV immunity in pregnant women;
* Evaluation of cellular and humoral immunity in cases with discrepancy between tests or between test and memory;
* Evaluation of acceptability of vaccination in the post partum period in non immune patients.
Methods Not randomized prospective study,
Number of patients : 400 Duration : 36 months Inclusion criteria : pregnant women \>18years old, agree to participate (written consent) Exclusion criteria: auto immune disease, HIV +, grafted patients
Conditions
- Pregnancy
Interventions
- BIOLOGICAL
-
Serological Test s for the Virus Chicken Pox Virus
Sponsors & Collaborators
-
Hopital Foch
lead OTHER
Principal Investigators
-
Olivier Picone, MD · Service Gynécologie Hopital Foch
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-03-30
- Primary Completion
- 2020-07-26
- Completion
- 2020-07-26
Countries
- France
Study Locations
More Related Trials
-
Study of Rubella Immunity. Response to Vaccination of Subjects With Very Low, Equivocal or Undetectable Titers of Rubella Virus Antibodies
NCT02934295 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate Immunogenicity and Safety After the First and Second Doses of MG1111 (BARYCELA Inj.) in Healthy Children Aged 12 Months to 12 Years
NCT07054099 ·Status: RECRUITING ·Phase: PHASE3
-
Safety and Immunogenicity Study of Live Attenuated Vaccine Against Varicella Without Gelatin
NCT01684072 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Healthy Population Aged ≥13 Years Old
NCT05158777 ·Status: COMPLETED ·Phase: PHASE3
-
The Safety, Immunogenicity and Immune Effect Research of the Varicella Vaccine After the 2nd Dose Vaccination
NCT01830283 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study to Evaluate Safety, Tolerability, and Immunogenicity of an Investigational Zoster Vaccine In Subjects With a History of Varicella (Chickenpox)(V211-010)(COMPLETED)
NCT00130793 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Participants Undergoing Hematopoietic Cell Transplants (HCTs) (V212-001)
NCT01229267 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Tolerability Study of the VAC∆6 Vaccine in Volunteers Aged 18-40 Years
NCT05762523 ·Status: COMPLETED ·Phase: PHASE1
-
Immunodeficiency in Cartilage-hair Hypoplasia: Sub-project on Safety of Vaccination Against Chickenpox
NCT02383797 ·Status: UNKNOWN ·Phase: PHASE4
-
Immunogenicity and Safety Study of 2 Doses of Live Attenuated Varicella Vaccine
NCT01817270 ·Status: COMPLETED ·Phase: PHASE4
-
Study on Immunogenicity, Reactogenicity and Safety of the VACΔ6 Vaccine in Volunteers Aged 18-60 Years
NCT05846243 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Evaluation of the Anti-VZV Vaccine Response of Patients With Immune-mediated Systemic Inflammatory Diseases Vaccinated in the Care Setting
NCT07047053 ·Status: RECRUITING
-
Evaluate the Safety and Immunogenicity After MG1111(BARICELA Inj.) as 2nd Vaccination in 4 ~ 6 Year Old Healthy Children With a History of 1st Varicella Vaccination
NCT05422508 ·Status: RECRUITING ·Phase: PHASE2
-
A Safety and Immune Study of 2 Types of GlaxoSmithKline's Varicella Vaccines Given as a 2-doses Course to Healthy Children 12-23 Months of Age.
NCT02570126 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of an Investigational Zoster Vaccine in Subjects With a History of Varicella (Chickenpox) Given Concomitantly With Another Vaccine (V211-011)
NCT00231816 ·Status: COMPLETED ·Phase: PHASE3
-
A Study on the Immune Response and Safety of Various Potencies of an Investigational Chickenpox Vaccine Compared With a Marketed Chickenpox Vaccine, Given to Healthy Children 12 to 15 Months of Age
NCT05084508 ·Status: COMPLETED ·Phase: PHASE2
-
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age
NCT06740630 ·Status: RECRUITING ·Phase: PHASE3
-
Study to Test the Safety and Immunogenicity of VARIVAX (2007 Process) (Study V210-057) (Completed)
NCT00822237 ·Status: COMPLETED ·Phase: PHASE3
-
Immune Persistence After Inoculated With One-dose Freeze-Dried Live Attenuated Varicella Vaccine in Children Vaccine in Children
NCT01982409 ·Status: UNKNOWN ·Phase: PHASE4
-
Serological Evaluation of Varicella and Hepatitis A Vaccines Using Injector Delivery
NCT00926419 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Immunogenicity and Safety of GSK Biologicals' Live Attenuated Varicella Vaccine (VARILRIXTM).
NCT00792623 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity of CVI-VZV-001 for Prevention of Herpes Zoster in Healthy Adults Age 50 Years and Above
NCT06137755 ·Status: RECRUITING ·Phase: PHASE1
-
Flucelvax (TIVc or QIVc) Pregnancy Registry
NCT03438487 ·Status: COMPLETED
-
Immunogenicity and Safety of 2 Doses of Live Attenuated Varicella Vaccine
NCT02173899 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Immunogenicity, Safety, and Tolerability of VARIVAX™ Manufactured With a New Process (V210-062)
NCT01626794 ·Status: WITHDRAWN ·Phase: PHASE3